Brad Kahl, MD

Brad Kahl, MD

Medical Oncologist

Primary Academic Title

Professor of Medicine, Division of Oncology Director, Lymphoma Program, Washington University School of Medicine

Clinical Expertise

Hematologic malignancies, lymphoma, chronic lymphocytic leukemia

Research Interest

My interests involve clinical and translational efforts to improve outcomes for lymphoma patients. I am particularly interested in novel agents and testing of those agents in clinical trials. I have led several clinical trials in the Eastern Cooperative Oncology Group and currently serve as Chair of the ECOG Lymphoma Committee.


  • 1994: MD, Tufts University School of Medicine, Boston


  • 1994 - 1998: Resident, internal medicine, University of Wisconsin, Madison
  • 1998 - 2000: Fellow, hematology, University of Wisconsin, Madison

Board Certification

  • 1997: American Board of Internal Medicine
  • 2001, 2011: American Board of Internal Medicine - Hematology

Selected Research Publications

Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy.
  • Crombie JL, Graff T, Falchi L, [...] Kahl BS, [...] Dickinson M
  • Blood 2024
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.
  • Cerhan JR, Maurer MJ, Link BK, [...] Kahl BS, [...] Flowers CR
  • Am J Hematol 2024
A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphoma.
  • Fehniger TA, Watkins MP, Ezenwajiaku N, [...] Kahl B, Bartlett NL
  • Haematologica 2024

View All Publications

Contact Information

  • Washington University Medical Campus

    4921 Parkview Place
    Saint Louis, MO 63110

  • South St. Louis County

    5225 Midamerica Plaza
    St. Louis, MO 63129

Phone Numbers

Request an appointment